IL10 and cancer: A 4-NQO carcinogen-driven mouse model of oral cancer revealed that the initial inflammatory profile present in pre-cancer (dominated by IFN-gamma and IL-17 along with other inflammatory mediators) [140] was succeeded by anti-inflammatory cytokine IL-10 as the lesions progressed to SCC [142].